ICUMICRO

SeaStar Medical Holding Corporation

HealthcareBiotechnology
$3.24
$0.00(+1.96%)
52W$0.22
$5.08
Updated Jun 22, 02:00 AM
RSI43
RS Rating98/99
Beta1.12
Volatility130%
F-Score4/9
Mkt Cap$127M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

SeaStar Medical Holding Corporation is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings growth of 80% provides fundamental context to the price action. Investors should exercise caution due to high volatility (130% annualized), which requires wider risk management.

Relative Strength
98
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.12
vs S&P 500
ABOVE MKT
52W Position
62%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.82
50 SMA > 100 SMA$3.27
100 SMA > 150 SMA$3.15
150 SMA > 200 SMA$4.07

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.22+0.59%ABOVE
50 SMA$3.82-15.21%BELOW
100 SMA$3.27-0.97%BELOW
150 SMA$3.15+3.00%ABOVE
200 SMA$4.07-20.38%BELOW

Price Performance

1D+2.0%
1W+14.3%
1M-22.0%
3M+32.8%
6M+9.6%
YTD+18.6%
1Y+219.6%
3Y-39.4%
52-Week Trading Range62% from low
$3.24
52W Low$0.22
52W High$5.08

Technical Indicators

RSI (14)NEUTRAL
42.8
305070
Setup ScoreCOOL
3/10
Base depth: 92.1%

Risk Profile

Beta
1.12
52W Vol
130%
ATR
$0.27
Max DD (1Y)
-82%

Volume Analysis

Today
59.6K
50D Avg
79.4K
Vol Ratio
0.75x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+89%
$-1.10
Q3'25+88%
$-1.30
Q4'25+91%
$-0.80
Q1'26+80%
$-0.90
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:+235.51%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+88.17%

Stock Price CAGR

10 Years:-35.66%
5 Years:-58.61%
3 Years:-39.44%
1 Year:+219.57%

Return on Equity

10Y Avg:-295.2%
5Y Avg:-295.2%
3Y Avg:-295.2%
Last Year:-146.3%

Key Metrics

Market Cap$127M
Gross Margin95.7%
Net Margin-9.8%
Piotroski F-Score4/9

Frequently Asked Questions

Is ICU in an uptrend right now?

ICU has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ICU overbought or oversold?

ICU's RSI (14) is 43. The stock is in neutral territory, neither overbought nor oversold.

Is ICU outperforming the market?

ICU has a Relative Strength (RS) Rating of 98 out of 99. Yes, ICU is a market leader, outperforming 98% of all stocks over the past 12 months.

Where is ICU in its 52-week range?

ICU is trading at $3.24, which is 64% of its 52-week high ($5.08) and 62% above its 52-week low ($0.22).

How volatile is ICU?

ICU has a Beta of 1.12 and 52-week volatility of 130%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.